News

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2020 Prize for Early-Career Cancer Researchers

September 30th, 2019 / PR Business Wire // The Pershing Square Sohn Cancer Research Alliance

September 30, 2019, New York, NY (BUSINESS WIRE): The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2020 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area-based scientists. … Continued

Horwitz Prize Awarded for Work on Critical Cancer Pathway

September 6th, 2019 / COLUMBIA UNIVERSITY IRVING MEDICAL CENTER

COLUMBIA UNIVERSITY IRVING MEDICAL CENTER/EUREKALERT – Columbia University will award the 2019 Louisa Gross Horwitz Prize to three scientists: Lewis C. Cantley, Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY, USA, David M. Sabatini, Massachusetts Institute of Technology, Cambridge, Massachusetts, and Howard Hughes Medical Institute, Chevy Chase, MD, USA, and Peter K. … Continued

Exploration of Pregnancy-Related Changes in Breast Tissue

August 6th, 2019 / Valerie Neff Newitt / Oncology Times

ONCOLOGY TIMES – A century-old medical understanding recognizes the fact that a full-term pregnancy early in a woman’s life dramatically decreases her risk of breast cancer. Camila dos Santos, PhD, Assistant Professor at the Cancer Center of Cold Spring Harbor Laboratory, wants to know more about that phenomenon. She has set about interrogating breast tissue—both … Continued

Discovery of a New Immune Process Could Lead to Better Pain Treatments

July 22nd, 2019 / MIRAGE News

MIRAGE NEWS – A molecular pathway known for responding to cellular stress also produces pain-inducing molecules in immune cells in mice, according to a new study by scientists at Dana-Farber Cancer Institute, Weill Cornell Medicine and Wake Forest University School of Medicine. The investigators found that blocking this pathway can reduce pain. The findings, published online in the … Continued

PRESS RELEASE: PERSHING SQUARE SOHN PRIZE AWARDS $4.2M TO SEVEN “NEXT GENERATION” INNOVATORS IN CANCER RESEARCH

May 21st, 2019 / The Pershing Square Sohn Cancer Research Alliance

PERSHING SQUARE SOHN PRIZE AWARDS $4.2M TO SEVEN “NEXT GENERATION” INNOVATORS IN CANCER RESEARCH The Pershing Square Sohn Cancer Research Alliance Has Invested Over $22 Million in the New York Life Science Ecosystem by Funding NYC’s Most Innovative Cancer Researchers NEW YORK, May 21, 2019 – The Pershing Square Sohn Cancer Research Alliance today announced … Continued

The Tisch Cancer Institute and Precision Immunology Institute at Mount Sinai Launch Center for Computational Immunology

May 10th, 2019 / Newswise / Mount Sinai Health System

Newswise — (New York, NY – May 9, 2019) — The Tisch Cancer Institute and the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have launched the Center for Computational Immunology, a hub that will help researchers studying cancer, genomics, machine learning, and immunology collaborate to find better targeted immunotherapies for patients. Benjamin … Continued

President Bruce Stillman wins prestigious Gairdner Award

April 2nd, 2019 / Sara Roncero-Menendez / COLD SPRING HARBOR LABORATORY

Cold Spring Harbor, NY — Dr. Bruce Stillman, President and CEO of Cold Spring Harbor Laboratory (CSHL), has been awarded the 2019 Canada Gairdner International Award in honor of his pivotal contributions to basic research. The Canada Gairdner International Award recognizes researchers who have made seminal discoveries or contributions to biomedical science. Dr. Stillman is being honored for “pioneering … Continued

Study identifies link between DNA-protein binding, cancer onset

October 26th, 2018 / HELEN SANTORO / STANFORD MEDICINE

Researchers at the Stanford University School of Medicine and their collaborators at other institutions have identified a link between how proteins bind to our DNA and how cancer develops. This finding may allow researchers to predict cancer pathways and long-term patient outcomes. The research focuses on chromatin, the DNA-protein complex where all genes reside. Specifically, it evaluates chromatin’s … Continued

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for the 2019 Prize for Early-Career Cancer Investigators

October 1st, 2018 / PR Business Wire // The Pershing Square Sohn Cancer Research Alliance

October 1, 2018, New York, NY (BUSINESS WIRE): The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2019 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area-based scientists. … Continued

New mRNA Cancer Drivers Revealed in Chronic Lymphocytic Leukemia

August 27th, 2018 / GenomeWeb

NEW YORK (GenomeWeb) – New evidence has emerged today showing that the inactivation or alteration of cancer suppressor genes can take place even if DNA itself remains unaltered. Reporting in Nature, investigators demonstrated that changes in mRNA due to a process called intronic polyadenylation (IPA) can drive development of some cancers by altering gene expression in … Continued